BioIVT
Hosting Partner
The field of advanced therapeutics, including cell and gene therapy, continues to hold remarkable promise for the treatment of cancer and other chronic conditions. BioIVT’s immune cell portfolio includes everything you need to develop advanced therapies. From industry-standard leukapheresis products to timesaving, ready-to-use isolated immune cell subsets, we provide the cells you need, when you need them. Through our 425 worldwide collections sites and 11 donor centers, we have an extensive network of healthy, recallable donors and truly representative starting material from oncology, autoimmune and infectious disease-state.
Charles River
Hosting Partner
Charles River Cell Solutions provides research-use and GMP-compliant human immune and stem cells to support basic research and advanced therapy development. With 45+ years of experience, we are built on the expertise of our legacy organizations, HemaCare and Key Biologics, and backed by decades of experience and an extensive donor network.
Accellix
Exhibition Partner
The Accellix Automated Cell Phenotyping Platform seamlessly integrates the capabilities of flow cytometry within the GMP manufacturing suite. By automating every strep from sample preparation to data acquisition and analysis, this platform excels in optimizing the intricate processes of incoming, in-process, and release quality control testing throughout the cell therapy manufacturing workflow. This empowers our valued cell therapy
partners to fulfil their essential quality control requirements whilst propelling life changing therapies that benefit patients worldwide.
Blood Centers of America
Exhibition Partner
BCA is the nation’s largest blood supply network, providing over 50 percent of the blood and blood components in U.S. This national organization is comprised of over 60 independent community blood centers with a deep local commitment to the communities and patients they serve. The BCA network encompasses over 500 collection and testing sites, across 43 states.
In addition to meeting the transfusion needs of the communities they serve, BCA members provide human blood products, custom collections, MNC-A leukopaks, cell processing, testing, cryopreservation, storage, distribution and other services to the therapeutic, diagnostic and cell therapy industries. The BCA Network includes over 400 apheresis collection devices across the U.S. supporting 30,000 annual healthy donor and patient cell therapy collections. This includes autologous, allogeneic and therapeutic apheresis collections. Collectively BCA’s members interact with nearly three million individual blood donors annually in addition to thousands of patients by providing collection services in hospital and blood centers’ facilities.